These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29500209)

  • 1. 7-day compared with 10-day antibiotic treatment for febrile urinary tract infections in children: protocol of a randomised controlled trial.
    Daniel M; Szajewska H; Pańczyk-Tomaszewska M
    BMJ Open; 2018 Mar; 8(3):e019479. PubMed ID: 29500209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children.
    Kornberg AE; Sherin K; Veiga P; Mydlow PK; Collins JJ; Feld LG
    Am J Nephrol; 1994; 14(3):169-72. PubMed ID: 7977475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).
    van Nieuwkoop C; van't Wout JW; Assendelft WJ; Elzevier HW; Leyten EM; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Kuijper EJ; Pander J; Blom JW; Spelt IC; van Dissel JT
    BMC Infect Dis; 2009 Aug; 9():131. PubMed ID: 19691829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
    van Nieuwkoop C; van der Starre WE; Stalenhoef JE; van Aartrijk AM; van der Reijden TJ; Vollaard AM; Delfos NM; van 't Wout JW; Blom JW; Spelt IC; Leyten EM; Koster T; Ablij HC; van der Beek MT; Knol MJ; van Dissel JT
    BMC Med; 2017 Apr; 15(1):70. PubMed ID: 28366170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualised versus standard duration of antibiotic therapy in children with acute uncomplicated febrile urinary tract infection: a study protocol and statistical analysis plan for a multicentre randomised clinical trial.
    Sethi N; Carlsen ELM; Schmidt IM; Cortes D; Nygaard U; Sehested LT
    BMJ Open; 2023 Jun; 13(6):e070888. PubMed ID: 37295836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional features of the microbial landscape of urine and comparative evaluation of antimicrobial therapy in children with cystitis.
    Kryuchko TO; Kharshman VP; Nesina IM; Kuzmenko NV; Oleksiienko JM
    Wiad Lek; 2017; 70(3 pt 2):566-570. PubMed ID: 28713083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial.
    Daniel M; Szymanik-Grzelak H; Turczyn A; Pańczyk-Tomaszewska M
    BMC Urol; 2020 Oct; 20(1):168. PubMed ID: 33097017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Lafaurie M; Chevret S; Fontaine JP; Mongiat-Artus P; de Lastours V; Escaut L; Jaureguiberry S; Bernard L; Bruyere F; Gatey C; Abgrall S; Ferreyra M; Aumaitre H; Aparicio C; Garrait V; Meyssonnier V; Bourgarit-Durand A; Chabrol A; Piet E; Talarmin JP; Morrier M; Canoui E; Charlier C; Etienne M; Pacanowski J; Grall N; Desseaux K; Empana-Barat F; Madeleine I; Bercot B; Molina JM; Lefort A;
    Clin Infect Dis; 2023 Jun; 76(12):2154-2162. PubMed ID: 36785526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
    Upchurch J; Rosemore M; Tosiello R; Kowalsky S; Echols R
    Otolaryngol Head Neck Surg; 2006 Oct; 135(4):511-7. PubMed ID: 17011409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety, efficacy, and tolerability of cefuroxime axetil suspension in infants and children receiving previous intravenous antibiotic therapy.
    Powell DA; Nahata MC; Powell NE; Ossi MJ
    DICP; 1991 Nov; 25(11):1236-8. PubMed ID: 1763541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic treatment of pyelonephritis in children. Recent advances].
    Montini G
    Recenti Prog Med; 2008; 99(7-8):343-6. PubMed ID: 18751612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial.
    Kristo A; Uhari M; Luotonen J; Ilkko E; Koivunen P; Alho OP
    Acta Paediatr; 2005 Sep; 94(9):1208-13. PubMed ID: 16278986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease.
    Eppes SC; Childs JA
    Pediatrics; 2002 Jun; 109(6):1173-7. PubMed ID: 12042561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy.
    Turik MA; Johns D
    J Chemother; 1998 Aug; 10(4):306-12. PubMed ID: 9720470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ; Heyder AM; Leroy B
    J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R; Berg O; Gehanno P; Leiberman A; Martinkenas JL; Nikolaidis P; Arvis P; Alefelder M; Reimnitz P
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.
    Jansåker F; Frimodt-Møller N; Bjerrum L; Dahl Knudsen J
    BMC Infect Dis; 2016 Dec; 16(1):727. PubMed ID: 27905884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.